Form 4 for TENX TENAX THERAPEUTICS, INC.
Accepted 2026-09-17 21:30:04 ET · period of report 2026-09-16 · accession 0001193125-26-394831 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 21:30 | 2026-09-16 | TENX | Doogan Declan | Dir | P - Purchase | $1.92 | +53.0K | 55.3K | +2,331% | +$101.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-16 | P | A | 53,000 | $1.92 | 55,274 | D | — | — |